Launch a U.S. limited market release of Omnipod 5 integrated with Dexcom G7 sensor
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 2 Nov 2023
- Due
- 30 Jun 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Planning for U.S. limited market release of Omnipod 5 integrated with Dexcom's G7 sensor in early 2024”
What we found
Evidence strength A What the grades mean
Filings state that in June 2024 Insulet began a full market release of Omnipod 5 with Dexcom's G7 CGM in the U.S., within the deadline, though not described as a limited release.
-
A Insulet Corporation 8-K filed 2024-08-08
“U.S. commercial launches: ◦Full market release of Omnipod 5 integrated with Dexcom’s G7 sensor” ✓ confirmed on the page
-
A Insulet Corporation 10-Q filed 2024-08-09
“In June 2024, we began our full market release of Omnipod 5 with Dexcom’s G7 CGM in the United States.” ✓ confirmed on the page
Market reaction: the shares moved -4.0% against the S&P 500 over the three sessions around the disclosure (7 Aug 2024 to 12 Aug 2024). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- Omnipod 5 with Dexcom G7 U.S. limited market release
- Where
- United States
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Insulet Corporation? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-PODD-006281 · Corrections policy